circNfix attenuates acute kidney injury by driving m6A-dependent degradation of YTHDF2 to stabilize DAPK2 mRNA
Clinical Science · 2026
DOI: 10.1042/cs20261973 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, 2026. Verfasst von Tongtong Ma und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524000, Guangdong, China. Hauptthemen laut MEDLINE: Acute Kidney Injury, RNA-Binding Proteins, RNA, Circular, Adenosine. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Although circular RNAs (circRNAs) have been implicated in acute kidney injury (AKI), their functional mechanisms beyond acting as miRNA sponges remain poorly understood, and the role of N6-methyladenosine (m6A) modification in circRNA-mediated regulation in AKI is yet to be explored. Here, we identify a novel mechanism by which the m6A-modified circRNA circNfix contributes to the regulation of septic AKI (SAKI). In tubular epithelial cells (TECs), down-regulation of RBM47 reduces circNfix expression during SAKI. m6A-modified circNfix scaffolds the E3 ligase HECTD1 to induce K48-linked polyubiquitination and proteasomal degradation of the m6A reader YTHDF2. This stabilizes DAPK2 mRNA, a key target of YTHDF2, inhibiting NF-κB activation, thereby reducing TEC apoptosis and inflammation. In mouse models of SAKI and ischemia–reperfusion injury-AKI, AAV-mediated circNfix delivery lowered YTHDF2, suppressed inflammation, improved renal function, and attenuated damage. In SAKI patients, circNfix levels in plasma and urine were significantly decreased, negatively correlated with serum creatinine. Urinary and plasma circNfix showed diagnostic potential. Our study reveals a mechanism where an m6A-modified circRNA contributes to AKI progression by degrading its reader protein, suggesting that circNfix may represent a potential therapeutic target and non-invasive biomarker.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524000, Guangdong, China.
- Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524000, Guangdong, China.
- Department of Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China.
- Department of Critical Care Medicine, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524000, China.
ORCID-Profile: Tongtong Ma, Peng Wang
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
Zitieren
APA
Ma, T., Zhang, Z., Yang, Y., Chen, C., Li, Z., Luo, H., Yu, Y., Huang, H., Chen, Z., & Wang, P. (2026). circNfix attenuates acute kidney injury by driving m6A-dependent degradation of YTHDF2 to stabilize DAPK2 mRNA. Clinical Science. https://doi.org/10.1042/cs20261973
Vancouver
Ma T, Zhang Z, Yang Y, Chen C, Li Z, Luo H, et al. circNfix attenuates acute kidney injury by driving m6A-dependent degradation of YTHDF2 to stabilize DAPK2 mRNA. Clinical Science. 2026. doi:10.1042/cs20261973
BibTeX
@article{Ma2026,
author = {Ma, Tongtong and Zhang, Ziqi and Yang, Yilin and Chen, Chaopeng and Li, Zhiyi and Luo, Huasheng and Yu, Yanmei and Huang, He and Chen, Zhongqing and Wang, Peng},
title = {circNfix attenuates acute kidney injury by driving m6A-dependent degradation of YTHDF2 to stabilize DAPK2 mRNA},
journal = {Clinical Science},
year = {2026},
doi = {10.1042/cs20261973}
}
EUVIMED